259 related articles for article (PubMed ID: 28419517)
21. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract][Full Text] [Related]
22. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.
Montoto S; López-Guillermo A; Colomer D; Esteve J; Bosch F; Ferrer A; Villamor N; Moreno C; Campo E; Montserrat E
Leuk Lymphoma; 2003 Jan; 44(1):71-6. PubMed ID: 12691144
[TBL] [Abstract][Full Text] [Related]
23. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.
Baró C; Espinet B; Salido M; García M; Sánchez B; Florensa L; Bellosillo B; Serrano S; Solé F
Leuk Res; 2011 Feb; 35(2):256-9. PubMed ID: 20952062
[TBL] [Abstract][Full Text] [Related]
24. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
Radojkovic M; Ristic S; Colovic M; Cemerikic-Martinovic V; Radojkovic D; Krtolica K
Neoplasma; 2008; 55(5):421-7. PubMed ID: 18665753
[TBL] [Abstract][Full Text] [Related]
26. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.
Macintyre EA; Belanger C; Debert C; Canioni D; Turhan AG; Azagury M; Hermine O; Varet B; Flandrin G; Schmitt C
Blood; 1995 Dec; 86(12):4691-8. PubMed ID: 8541563
[TBL] [Abstract][Full Text] [Related]
27. Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.
Galoin S; al Saati T; Schlaifer D; Huynh A; Attal M; Delsol G
Br J Haematol; 1996 Sep; 94(4):676-84. PubMed ID: 8826892
[TBL] [Abstract][Full Text] [Related]
28. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.
Spence JM; Rothberg PG; Wang N; Burack WR
J Mol Diagn; 2011 May; 13(3):252-62. PubMed ID: 21497287
[TBL] [Abstract][Full Text] [Related]
30. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
31. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
[TBL] [Abstract][Full Text] [Related]
32. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
Ladanyi M; Wang S
Diagn Mol Pathol; 1992 Mar; 1(1):31-5. PubMed ID: 1342952
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Della Starza I; De Novi LA; Cavalli M; Novelli N; Soscia R; Genuardi E; Mantoan B; Drandi D; Ferrante M; Monitillo L; Barbero D; Ciabatti E; Grassi S; Bomben R; Degan M; Gattei V; Galimberti S; Di Rocco A; Martelli M; Cortelazzo S; Guarini A; Foà R; Ladetto M; Ferrero S; Del Giudice I;
Hematol Oncol; 2020 Dec; 38(5):698-704. PubMed ID: 32816326
[TBL] [Abstract][Full Text] [Related]
34. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
[TBL] [Abstract][Full Text] [Related]
35. PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal.
Aiello A; Delia D; Giardini R; Alasio L; Bartoli C; Pierotti MA; Pilotti S
Diagn Mol Pathol; 1997 Jun; 6(3):154-60. PubMed ID: 9276187
[TBL] [Abstract][Full Text] [Related]
36. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
[TBL] [Abstract][Full Text] [Related]
37. Role of the molecular staging and response in the management of follicular lymphoma patients.
Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
[TBL] [Abstract][Full Text] [Related]
38. Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Gimenez E; Chauvet M; Rabin L; Puteaud I; Duley S; Hamaidia S; Bruder J; Rolland-Neyret V; Le Gouill S; Tournilhac O; Voog E; Maisonneuve H; Jacob MC; Leroux D; Béné MC; Formisano-Tréziny C; Gabert J; Gressin R; Callanan MB
Br J Haematol; 2012 Jul; 158(2):186-197. PubMed ID: 22626453
[TBL] [Abstract][Full Text] [Related]
39. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
Della Starza I; Nunes V; Cavalli M; De Novi LA; Ilari C; Apicella V; Vitale A; Testi AM; Del Giudice I; Chiaretti S; Foà R; Guarini A
Br J Haematol; 2016 Aug; 174(4):541-9. PubMed ID: 27172403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
